Allogeneic BMT in a patient with CML and schizophrenia

被引：0
|
作者：
Lightowler, J [1 ]
Feldman, E [1 ]
Ellis, M [1 ]
Littlewood, TJ [1 ]
机构：
[1] Oxford Radcliffe NHS Trust, Oxford, England
来源：
BONE MARROW TRANSPLANTATION | 1998年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
281
引用
收藏
页码：S80 / S80
页数：1
相关论文
共 50 条
  • [21] Reconstitution with Philadelphia chromosome-negative recipient haematopoiesis early after allogeneic BMT for CML
    Sill, H
    Rule, SAJ
    Joske, DJL
    Chase, A
    Lin, F
    Goldman, JM
    Cross, NCP
    BONE MARROW TRANSPLANTATION, 1996, 17 (03) : 453 - 455
  • [22] Relapse after allogeneic BMT for CML may be sustained by a low number of leukemic ''stem cells''.
    Podesta, M
    Piaggio, G
    Pitto, A
    Fugazza, G
    Mordini, N
    Berisso, G
    Soracco, M
    Sessarego, M
    Zikos, P
    Bacigalupo, A
    Frassoni, F
    BLOOD, 1997, 90 (10) : 4011 - 4011
  • [23] Effect of bone marrow fibrosis on outcome of allogeneic BMT in chronic phase Ph+ CML
    Thiele, J
    Kvasnicka, HM
    Beelen, D
    Fischer, R
    Schaefer, UW
    BONE MARROW TRANSPLANTATION, 1999, 23 : S62 - S62
  • [24] ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) IN PATIENTS WITH CHRONIC MYELOCYTIC-LEUKEMIA (CML)
    EHNINGER, G
    OSTENDORF, P
    HAEN, M
    LINK, H
    DOPFER, R
    NIETHAMMER, D
    HUBENER, K
    BREITLING, G
    SCHNEIDER, W
    WALLER, HD
    BLUT, 1985, 51 (03): : 159 - 159
  • [25] Improved survival of patients with chronic myelogenous leukemia (CML) undergoing allogeneic bone marrow transplantation (BMT).
    Moreb, J
    Johnson, T
    Kubilis, P
    Myers, L
    BLOOD, 1995, 86 (10) : 3826 - 3826
  • [26] RELAPSE AFTER ALLOGENEIC BMT FOR PH-1+ CML IN CP - A CYTOGENETIC ANALYSIS OF 13 CASES
    ROSTI, G
    ZACCARIA, A
    TESTONI, N
    CELSO, B
    BANDINI, G
    RICCI, P
    TASSINARI, A
    TURA, S
    SESSAREGO, M
    FRASSONI, F
    MARMONT, A
    BARONCIANI, D
    FILIPPETTI, A
    DIBARTOLOMEO, P
    DIGIROLAMO, G
    PALKA, G
    HINTERBERGER, W
    POLLAK, C
    HAAS, OA
    ARNOLD, R
    HEINZE, B
    MICHAUX, JL
    FERRANT, A
    MECUCCI, C
    VANDENBERGHE, H
    GAHRTON, G
    LINDQUIST, R
    BONE MARROW TRANSPLANTATION, 1988, 3 : 184 - 184
  • [27] Allogeneic bone marrow transplantation (BMT) for adults with chronic myeloid leukemia (CML) in accelerated phase (AP).
    Berkahn, LC
    Fung, HC
    Horsman, DE
    Le, A
    Nantel, SH
    Shepherd, JD
    Toze, CL
    Sutherland, HJ
    Klingemann, HG
    Barnett, MJ
    BLOOD, 1995, 86 (10) : 373 - 373
  • [28] IV busulfan, cyclophosphamide (BuCy) and allogeneic hemopoietic stem cells (BMT) for chronic myeloid leukemia (CML).
    Andersson, BS
    McWilliams, K
    Tran, H
    Fernandez, H
    Cagnoni, P
    Jones, R
    Gian, V
    Tarantolo, S
    Kashyap, A
    Forman, SJ
    Hu, WW
    Blume, KG
    Champlin, RE
    BLOOD, 1998, 92 (10) : 285A - 285A
  • [29] ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOGENEOUS LEUKEMIA (CML) IN CHRONIC PHASE (CP)
    PAPA, G
    ARCESE, W
    ARCANGELI, G
    MAURO, FR
    BIANCHI, A
    GUERRA, A
    ISACCHI, G
    GALLERANO, T
    VENDITTI, M
    DIVERIO, D
    ADORNO, G
    PURPURA, M
    QUINTILIANI, L
    FILIPPINI, A
    MANDELLI, F
    EXPERIMENTAL HEMATOLOGY, 1985, 13 : 38 - 38
  • [30] The correlation of cytokine gene polymorphisms with outcome in chronic phase CML patients undergoing allogeneic BMT.
    Neylon, AJ
    O'Brien, SG
    Szydlo, R
    Brookes, PA
    Goldman, JM
    Middleton, PG
    BLOOD, 2001, 98 (11) : 349A - 349A
12345